glutathione instability Metabolism - an overview Measurement of Glutathione as a

Finally, we review current preclinical efforts to target FSP1, with emphasis on small-molecule inhibitors, mechanism-based combinations, candidate biomarkers, and major translational challenges

& Clemens, J

The synergy isn't additiveit's multiplicative, provided dosing timing prevents competitive inhibition at the cellular level

In more than 70% of CLL patients, del(17p) co-exists with TP53 mutations in the second allele, explaining complete loss of p53 activity in these cases [422, 429,430,431,432,433]

10.1038/onc.2015.20 [DOI] [PubMed] [Google Scholar] Gui Y., Yeganeh M., Ramanathan S., Leblanc C., Pomerleau V., Ferbeyre G., et al

All treatments are performed or supervised by licensed medical professionals